Your session is about to expire
← Back to Search
Shorter Course Radiation for Breast Cancer
Study Summary
This trial is testing a new, shorter radiation treatment for breast cancer patients who have had surgery to remove cancerous lymph nodes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- It's been over 6 months since my breast surgery or chemotherapy.I have had radiation therapy on the same side of my chest or breast before.I am a woman under 50, had chemotherapy, have a specific cancer stage, or am large-breasted.I have an active collagen disease like lupus, scleroderma, or dermatomyositis with symptoms.I have had another type of cancer besides skin cancer within the last 5 years.I am a male.I am a woman with advanced breast cancer.I have chosen not to have or haven't had surgery for my condition.I am a woman who had cancer cells found at the edge of the tissue removed during my first surgery.My cancer has spread to lymph nodes in a way that surgery can't easily remove.I have cancer in both breasts at the same time.My cancer has spread far, or I've been told I have less than 5 years to live.My breast cancer stage fits specific criteria after surgery and before any advanced treatment.Side effects from my previous chemotherapy that could affect radiation treatment have gone away.My last breast cancer surgery was less than 6 months ago, and I haven't had chemotherapy after.My breast cancer has not spread to my lymph nodes.My cancer has not been confirmed to spread to my lymph nodes.I don't have any other serious illnesses that would stop me from participating in the study.I am an adult woman with breast cancer, had surgery, and my lymph nodes were affected.My surgery will include checking the lymph nodes in my armpit.I am fully active or able to carry out light work.I am under 18 years old.I have had either a total mastectomy or a lumpectomy.My last chemotherapy was within the last 6 months.My surgical wound has fully healed without any infection.
- Group 1: Adjuvant Hypofractionated Radiation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
May I partake in the experiment under consideration?
"At the moment, this medical trial is recruiting 112 individuals aged between 18 and 101 who have been diagnosed with breast cancer. Patients must meet certain criteria to be accepted into the study including: recovery from surgery without any infection or post-chemotherapy toxicity, Eastern Cooperative Oncology Group (ECOG) performance status of 0/1 (KPS >70%), AJCC 7th ed. Stage cN0 or cN1 subsequently staged after surgery as Stage pIB (N1mic), pIIA, pIIB, pIIIA, or pIIIB; those below 50 years old are also eligible if pathologic"
Does this trial offer enrollment for seniors aged 60 and over?
"This clinical trial is seeking participants who are 18 years of age or older, but have yet to reach the century mark."
What results are scientists hoping to achieve through this clinical trial?
"Over a span of 60 months, this clinical trial shall assess the prevalence of symptomatic rib fractures through plain film or CT scans. Additional secondary outcomes involve metrics such as metastasis-free survival (calculated from enrolment to detection of distant metastases and death), quality of life scores reported by EORTC QLQ-C3014 and breast cancer module (BR23), and recurrence rates within axillary lymph nodes I, II, III without supraclavicular region included."
Are this trial's enrollment criteria still open for new participants?
"Unfortunately, clinicaltrials.gov does not list this trial as actively recruiting; the most recent update was made on August 30th 2022. Fortunately, 2600 other clinical studies are accepting participants at present."
Has Adjuvant Hypofractionated Radiation been given regulatory approval yet?
"As this trial is in its second phase, there are data points that suggest adjuvant hypofractionated radiation's safety. Therefore the risk factor was assigned a score of 2."
Share this study with friends
Copy Link
Messenger